when will retatrutide be fda approved Trial of next-gen weight-loss drug brings it one step closer to approval Eli Lilly plans to pursue

Trujillo, J.M., Nuffer, W., and Smith, B.A

At the damaging level, high-dose/chronic exposure drives HF progression through synergistic multi-pathway mechanisms: inflammation, oxidative stress, fibrosis, metabolic derangement, and direct cardiac/electrophysiological impairments

The existence of an evolutionarily-conserved ergothioneine-dedicated cellular transporter speaks volumes about how important this molecule is for human longevity

In this installment, were highlighting safety updates concerning these drugs: Byetta, Bydureon BCISE, Mounjaro, Saxenda, Soliqua 100/33, Trulicity, Victoza, and Xultophy 100/3.6

GHK-Cu has an excellent safety profile backed by over 50 years of research and more than 70 published studies